Business Overview

QXO is Brad Jacobs' building products distribution roll-up. The company acquired Beacon Roofing Supply for $10.6B (closed April 2025) and announced Kodiak Building Partners for $2.25B (expected close Q2 2026). Pro forma revenue: ≈$12B. This is Year 1 of a stated decade-long consolidation targeting $50B revenue from an $800B fragmented market.

The core business is straightforward. Buy branded building products from a handful of manufacturers (Owens Corning, GAF, Carlisle -- three suppliers represent ≈35% of purchases), warehouse them at ≈600 branches, sell to 110,000+ contractors who need just-in-time delivery to job sites. The distributor adds value through product bundling, last-mile logistics, trade credit, and digital ordering. No customer exceeds 1% of revenue.

Revenue composition (Beacon, 8 months Apr-Dec 2025):

• Residential roofing (shingles): $3.3B, 48%
• Non-residential roofing (single-ply membranes): $1.9B, 28%
• Complementary building products: $1.6B, 23%
• Software (legacy SilverSun): $59M, 1%

Kodiak adds lumber, trusses, windows, doors, gypsum, and construction supplies -- diversifying QXO beyond roofing into broader building products.

End market mix matters. Approximately 80% of revenue comes from repair and replacement (R&R), of which 94% is non-discretionary -- roofs wear out, building codes mandate replacement, insurance requires it. Only ≈20% is tied to new construction, the cyclical component. This makes QXO structurally less cyclical than homebuilders, though storm-driven demand is a real swing factor (zero named storms in 2025 was a material revenue headwind).

How the roll-up creates value: Four mechanisms. (1) Purchasing leverage -- larger volumes improve manufacturer rebates ($427M in vendor rebates receivable at year-end, roughly 6% of COGS). (2) Operational efficiency -- shared back-office, branch consolidation, delivery route optimization. QXO already took a $100.7M restructuring charge in its first 8 months. (3) Technology deployment -- AI-driven pricing, digital sales platform, inventory optimization. This is Jacobs' stated differentiator. (4) Cross-selling -- Beacon's roofing customers buy waterproofing and siding; Kodiak's lumber customers need roofing. Combined platform can bundle across categories.

Private label (TRI-BUILT brand) is worth highlighting: 500-2,000 basis points margin premium over branded alternatives, growing 7% in 2024, with an exclusive brand that competitors can't carry. Digital sales at 16% of total and growing 20% annually carry 150bps higher margins and produce larger basket sizes. These are genuine competitive differentiators, though still small relative to the whole.

Financial Profile

Revenue trajectory: decelerating, now declining organically

Beacon grew from $6.6B (FY2021) to $9.8B (FY2024) -- explosive post-COVID (+27% in FY2022), decelerating to +7% by FY2024, increasingly driven by tuck-in acquisitions rather than organic growth. The deceleration was already underway before Jacobs arrived.

On a pro forma basis (as if Beacon owned from Jan 1 each year), QXO's revenue declined 2.9% in 2025: $9.82B to $9.54B. This is the first decline in the dataset. Multiple counterparties confirm the cause was largely exogenous -- zero named storms, severe winter, and channel destocking. Owens Corning, Carlisle, and Home Depot all confirm and expect normalization in H2 2026. But the organic trajectory going into the acquisition was already flat to down, and HD/SRS grew through the same environment by investing in price for share.

Margin structure: stable but thin

Gross margins have been remarkably consistent at 25.5-26.5% over four years, compressing slightly to 24.9% adjusted in the 8-month QXO period. This is typical for specialty distribution -- pricing is cost-plus with some spread management. The slight compression likely reflects seasonal mix, integration disruption, and weak demand.

Adjusted EBITDA margin: 9.5% for the 8-month QXO period, roughly in line with Beacon's standalone ≈9.4% in FY2024. Beacon's peak was 10.2% in FY2022. Operating leverage exists but cuts both ways -- Beacon's operating margin declined from 8.3% to 6.8% despite revenue growth as SG&A inflation and acquisition-related D&A outpaced topline.

Management targets 11-13% EBITDA margin over 3-5 years. The gap from 9.5% to 12% is 250bps. At $12B revenue, that's $300M of incremental EBITDA. Where it comes from: private label penetration, digital cost-to-serve reduction, AI pricing optimization, SG&A rationalization, purchasing scale on Kodiak volumes. The XPO analog: it took 3-5 years to show meaningful margin improvement. There's no public timeline or milestone markers for QXO.

The GAAP-to-adjusted bridge tells the story

QXO reported a GAAP net loss of $279M against adjusted EBITDA of $648M -- a $927M gap. The major add-backs:

If you add back only amortization, inventory fair value, debt extinguishment, and restructuring (the genuinely non-cash/non-recurring items), adjusted EBITDA drops from $648M to roughly $563M. If you further deduct SBC as a real expense, it's $418M. The range of "true" EBITDA depends on what you believe recurs: $563M (generous) to $418M (conservative).

The $145M in SBC is 22% of adjusted EBITDA. This is not a rounding error. Management excludes it from adjusted metrics. Whether you deduct SBC from EBITDA or count the dilutive shares, you must do one -- not neither. The SBC creates real dilution through a 2024 Omnibus Plan with a 3% annual auto-increase calculated on common outstanding PLUS as-converted CPP shares (≈893.5M base per 10-K Note 8) -- producing ≈26.8M new shares per year. The 2026 plan limit reached 62.0M shares.

"Transformation costs" is a category that didn't exist at Beacon. $45M in undefined spend that management deems non-operational. For a company whose entire thesis is technology-driven transformation, these costs ARE the business model.

Free cash flow: thin and getting thinner

Beacon generated normalized FCF of roughly $350-400M per year on ≈$10B revenue (3.5-4% FCF margin). The business is working-capital intensive -- every $1B of revenue growth requires ≈$170M of incremental working capital investment. The cash conversion cycle is approximately 69 days.

For the 8-month QXO period, OCF was $261M and capex $78M, producing $183M of FCF. After $105M in preferred dividends (CPP $90M + Mandatory Convertible $15M), FCF to common was $78M. On a $15.6B market cap, that's a 0.5% yield.

Annualized and normalized, the math improves but not dramatically. Assume $1B EBITDA run rate, ≈$150M interest, ≈$78M capex, ≈$195M cash taxes (at 26.3% effective rate on ≈$742M taxable income), ≈$120M preferred dividends -- FCF to common is approximately $457M, a 2.9% yield. If Apollo's $3B Series C is drawn at 4.75%, add another $143M in preferred dividends. FCF to common drops to ≈$314M, a 2.0% yield.

The preferred dividend burden is growing. Currently $122M annual ($90M CPP + $32M Mandatory). If Apollo is fully drawn: $265M+. At $457M normalized FCF to common, the preferred consumes 27% of free cash flow before common holders see anything. Fully drawn, that ratio climbs to 45%.

Capital Structure and Dilution

This is the most important section of this memo.

The share count problem

The 10-K (Note 7) discloses 496.9M potential dilutive securities excluded from loss-per-share as anti-dilutive. Add post-year-end issuances:

Critical detail: the warrants are exercisable ONLY via cashless exercise (10-K, Note 7). The holder receives net shares equal to (stock price - exercise price) / stock price x warrant shares. At $22, this produces ≈145M net shares rather than 219M gross -- but NO cash proceeds flow to the company. For EV purposes, this roughly nets out: fewer dilutive shares but no proceeds offset. The table above uses gross shares per the 10-K's own anti-dilutive securities disclosure.

The CPP and warrants WILL convert. The exercise prices ($4.57-$13.70) are so far below market that conversion is effectively certain -- the only question is timing. The Mandatory Convertible converts automatically in May 2028 regardless of price. These are not contingent claims. They are future shares with current certainty.

The 10-K itself uses 727.3M adjusted diluted weighted-average shares for its $0.34 adjusted EPS. This weighted-average figure understates the fully diluted share count because it averages over a period when many securities weren't yet outstanding. On ≈1,258M fully diluted shares, the $22 stock implies a $27.8B equity value. At the $30 analyst consensus, it's $37.7B.

What this means for valuation

Note: Fully diluted EV uses gross warrant shares (per 10-K disclosure) with no proceeds offset, since warrants are cashless-exercise-only. Using net cashless shares (≈145M at $22) instead of gross (219M) gives a similar EV (≈$26.9B) because fewer shares are offset by zero proceeds.

Distribution comps trade at 10-14x EBITDA. Beacon pre-bid traded at ≈11x. SRS sold to Home Depot at ≈14x (the high-water mark).

At 18.1x on current shares, QXO trades at a 29-81% premium to comps. At 26.8x fully diluted, it's 91-168% premium. The premium is the Jacobs execution premium -- the market's bet that M&A and margin improvement will drive EBITDA materially higher.

JPE economics vs. common shareholder economics

JPE (Jacobs Private Equity) paid ≈$1B for its CPP and warrants. Because the warrants are cashless-exercise-only, JPE's net shares at $22 are approximately 219M (CPP) + 145M (net warrant shares) = ≈364M shares, worth ≈$8.0B -- an 8x return on invested capital before a single operational improvement. Common shareholders at $22 need the stock to nearly double to achieve a 2x return.

Jacobs' interests are directionally aligned with common shareholders -- he bought $57M in open market at $22 in December-January. But structurally, JPE's cost basis is so low that growth at almost any cost of dilution is accretive to JPE, even if it dilutes common holders. This is the core tension in the capital structure.

Competitive Position

Narrow moat, not wide

The competitive advantages are real but not durable enough to justify "wide moat" classification:

Defensible: 600-branch physical network (expensive to replicate), customer fragmentation (110K+ customers, behavioral switching costs from trade credit and ordering habits), digital platform leadership (16% penetration, growing 20% annually with 150bps margin uplift), private label (TRI-BUILT, 500-2000bps margin premium), and scale purchasing power ($10B+ volumes generating better rebates than any independent).

Commoditized: The product itself is identical across distributors -- an Owens Corning shingle from QXO is the same shingle from ABC Supply. No contractual lock-in with customers. Low barriers to local market entry (one warehouse, one truck). Pricing is transparent and competitive.

The competitive threats consensus underweights

HD/SRS is the most dangerous competitor. Home Depot acquired SRS for $18.25B in 2024 and is investing aggressively. Key data points from HD's Q4 2025 earnings call: SRS grew organic low-single-digit while ARMA shingle volumes were down 28% in Q4 -- they took share by investing in price. 40-50 new SRS locations planned for 2026. GMS acquisition (drywall, ceiling, steel framing) adds product categories. The cross-selling ecosystem (HD retail + SRS specialty + GMS interior + HD Supply maintenance) is unreplicable.

HD management described SRS as having "took opportunity, fully take share" and characterized Q4 pricing as investing in share gains (paraphrased from Q4 2025 transcript). This is a competitor with infinite balance sheet relative to QXO, willing to sacrifice margin for market position. When QXO attempts margin expansion, HD/SRS is simultaneously compressing industry margins to gain share. These two strategies collide.

Manufacturer disintermediation is accelerating. Owens Corning's Pink Advantage Dealer Program now enrolls 4,000 privately owned building materials dealers, with enrollment growing 38% in 2025 (per OC Q4 2025 transcript). OC is building direct contractor loyalty THROUGH distribution but creating brand allegiance to OC, not to the distributor. Holcim/AMRZ operates 30% direct and 70% through distribution, explicitly stating they focus on "end customer, not distributor." CSL is the exception -- their specification-driven model works through distributors.

The implication: manufacturers are testing how much they need large distributors. If the answer is "less than before," then QXO's value proposition narrows to logistics fulfillment -- a lower-margin, more commoditized business. The distributor becomes a shipping layer rather than a relationship owner.

Counter-argument: Distributors handle thousands of SKUs from dozens of manufacturers. No single manufacturer can replicate the aggregation function. Disintermediation is margin pressure risk, not existential replacement risk. And QXO's scale allows it to be the lowest-cost fulfillment layer if it executes on technology.

Management and Governance

Brad Jacobs: the thesis IS the person

Track record across United Rentals ($80B+ EV today), XPO, GXO, RXO: 500+ acquisitions, $50B+ capital raised, multiple multi-billion-dollar companies built through the same playbook. In equipment rental (URI), he took a fragmented industry and created the dominant scaled platform. The building products distribution playbook is structurally identical.

The C-suite is an M&A execution team: investment banker CFO (Essaid, former Barclays M&A head), deal lawyer CLO (Signorello, followed Jacobs from XPO), and a credible CTO (Liborski, ex-Amazon). No COO. Operations are run by Beacon/Kodiak legacy management below C-suite.

Insider buying is the strongest signal. $66M in open market purchases in December 2025 - January 2026: Jacobs $57M, Essaid $10M, Signorello $1.6M. All at ≈$22/share. These are P-coded open market buys -- real cash, not grants. Jacobs already has ≈$8B of JPE exposure (at $22, after accounting for cashless warrant exercise mechanics); adding $57M at the same price common shareholders pay is incremental conviction. No insider selling observed.

Governance: controlled company in practice

JPE holds 39.4% of voting power and has the right to designate 40% of the board at >30% ownership. This is effective control without majority ownership. Common shareholders have limited say on capital allocation, compensation, or strategic direction.

No DEF 14A has been filed yet (due April 2026), so independent board composition, committee structure, and executive compensation detail remain invisible. The 2024 Omnibus Plan with its 3% annual auto-increase is the only window into compensation philosophy -- and it's aggressive.

Key person risk is existential. Jacobs is 69. The 10-K explicitly names dependence on him in two separate risk factors. No succession plan is disclosed. The roll-up needs 8-10 years to reach $50B. If Jacobs exits the picture, the entire thesis collapses -- he IS the thesis. Investors in QXO common stock are making a concentrated bet on one person executing one playbook over a decade.

Factor Profile

Factor regression (251 trading days, iev regress) shows QXO is a company bet, not a factor bet:

80% idiosyncratic variance in the parsimonious model, but this result is transitional. Approximately half the 251-day regression window reflects QXO as a shell company (SilverSun Technologies). The factor profile will change materially as more post-acquisition data enters the window -- expect higher XLI/XHB loading and lower idio variance by late 2026. For now, the regression indicates QXO is a company bet rather than a factor bet, but the specific numbers should not be used for sizing or portfolio construction until the window is clean.

For context, peers are factor stocks: BLDR has 64% idio (43% XLI loading, negative alpha -- it's an industrials bet). HD has 70% idio (51% SPY -- it's a market proxy). QXO is differentiated.

The +33% annualized alpha is transitional repricing from shell company to $12B distributor. It will decay as the market fully prices the Beacon acquisition. Future alpha, if any, comes from margin improvement execution and accretive M&A.

Volatility: 54% idiosyncratic vol, 2.7x BLDR and 2.7x HD. ATM IV at 90.6% (98th percentile). 17.5% short interest (3x BLDR, 17x HD). The 2.42 yfinance beta is misleading -- the regression shows near-zero SPY beta when properly decomposed. The high beta is correlated factor exposures (XLI, IWM) being collapsed into a single number.

Forward Expectations Gap Analysis

What $22 requires to be true

To justify $22 at a 14x exit multiple (generous for distribution):

On current shares (748M): EV of $18.1B requires $1.29B EBITDA. That's 29% growth from the ≈$1B pro forma run rate. Achievable with Kodiak accretion plus modest margin improvement. Not heroic.

On fully diluted shares (≈1,258M): EV of ≈$26.8B requires ≈$1.91B EBITDA. That's 91% growth -- roughly doubling EBITDA. Requires either $50B revenue at current margins (Jacobs' decade-long target), $16B revenue at 12% margin, or significant additional M&A at attractive multiples plus margin improvement.

The consensus analyst target of $30 on fully diluted shares implies ≈$37.7B equity value, requiring ≈$2.7B EBITDA at 14x. That's a $50B+ revenue company at 12% margins. The endgame.

Six key disconnects

1. EBITDA quality. Management says $1B+ run rate. But $145M of SBC (22% of adjusted EBITDA) is treated as non-operational. Transaction costs ($84M) and "transformation" ($45M) will recur with each acquisition. A conservative EBITDA range: $563M (adding back only non-cash/non-recurring items) to $418M (also deducting SBC). Either figure is well below the $648M headline.

2. Share count. The 10-K uses 727.3M adjusted diluted weighted-average shares. Full dilution is 1,258-1,387M. The CPP and warrants are so deeply in the money that conversion is certain. The difference between $22 being "defensible" and "requires doubling EBITDA" is entirely which share count you use.

3. Organic growth. Pro forma revenue declined 2.9% ($9.82B to $9.54B). Management's $50B target includes "accretive acquisitions and organic growth, including greenfield openings" (10-K), but the organic component is negligible in the current environment. Counterparties confirm H2 2026 normalization is likely, but HD/SRS is simultaneously taking share.

4. Margin expansion vs. competitive pressure. Management targets 11-13% EBITDA margins. But HD/SRS is deliberately investing in price to gain share -- infinite balance sheet vs. QXO's levered structure. OC's Pink Advantage is reducing distributor value-add. CSL confirms commercial roofing pricing flat to down 1%. The pricing environment does not support margin expansion through revenue leverage; it must come entirely from cost reduction.

5. Preferred dividend drag. $122M annual currently. If Apollo $3B drawn: $247M+. No analyst appears to model the full preferred burden with Apollo drawn. On $400M normalized FCF, the preferred consumes 26-62% before common holders see anything.

6. Capital structure complexity. The gap between JPE's economics (≈8x return at $22) and common shareholders' economics (need stock to nearly double for 2x) creates structural tension. Growth at any dilution cost is accretive to JPE. Common holders need per-share value growth, which requires EBITDA growth to outrun dilution.

Options-implied expectations

Jan 2027 LEAPS show aggressively bullish positioning: P/C ratio of 0.17 (5.8x calls vs puts). The options market implies ≈42% probability of $30+ and ≈15% probability of $15 or below by January 2027. Call IV exceeds put IV by 3.9%, suggesting strong demand for upside participation, likely from event-driven/M&A buyers.

Key Risks

1. Dilution is not a risk -- it's a certainty. 496.9M potential dilutive shares (74% of basic count) will convert. The only questions are timing and whether per-share value grows faster than dilution. At URI, the answer was decisively yes. At QXO, it depends on margin improvement and acquisition multiples.

2. Key person dependency. Brad Jacobs, 69, no succession plan, explicitly named in two 10-K risk factors. The roll-up needs a decade. The actuarial math is uncomfortable.

3. Competitive intensification. HD/SRS has Home Depot's $165B balance sheet and is investing in price for share. ABC Supply is private with patient capital. Both are expanding footprints while QXO is still digesting Beacon.

4. Manufacturer disintermediation. OC Pink Advantage dealer enrollment growing 38% in 2025. Holcim operating 30% direct. Manufacturers are building contractor loyalty directly, reducing distributor value-add to logistics fulfillment.

5. Goodwill impairment. $5.1B goodwill + $3.8B intangibles = 56% of total assets, 92% of total equity. If the business deteriorates or acquisitions underperform, impairment charges could be massive. Purchase price allocation is still preliminary (10 months post-close).

6. Working capital trap. Every $1B of revenue growth requires ≈$170M of working capital investment. Growing to $50B means ≈$7B in cumulative working capital consumption. This is funded by debt or equity, both of which dilute or lever the balance sheet.

7. Tariff exposure. Expanded risk factor in the 10-K. Steel, imported building materials, and potential trade war impacts are new risks relative to predecessor Beacon filings.

8. Capital market dependency. The $50B target requires deploying $30-50B of capital. QXO has ≈$6B of firepower (cash + Apollo commitment). The remaining $25-45B must come from equity raises, additional preferred, or debt -- all of which dilute or lever existing common holders.

What to Watch

May 7, 2026 -- Q1 2026 earnings call. The first real investor engagement as QXO. Management will need to provide: Kodiak integration timeline, margin improvement roadmap, organic growth outlook, and SBC normalization guidance. The pre-announcement Q4 press release was financial tables and a Jacobs quote. The market is hungry for detail.

Q2 2026 -- Kodiak close. HSR approval and transaction completion. Dissenting share provision (max 3% walk right). The $40/share call option on Consideration Shares tells you Jacobs expects the stock well above $40 eventually.

H2 2026 -- Storm season and restocking. Every counterparty expects demand normalization. If storms don't materialize again, the organic revenue trajectory stays negative. If a major storm hits, it's a meaningful revenue tailwind.

Apollo Series C activation. Does Kodiak trigger the "Qualifying Acquisition" draw? If yes, $3B of preferred stock gets issued, adding $143M in annual dividends and 129M potential dilutive shares. This is the single largest incremental dilution event ahead.

SBC run-rate normalization. Was 2025 front-loaded with acquisition grants ($217M annualized) or is this the new run rate? If it normalizes to $80-100M, the EBITDA quality gap narrows meaningfully. If it persists at $200M+, that's a permanent ≈2% of revenue drag that management excludes from adjusted metrics.

Post-DEF 14A governance clarity. Due April 2026. First look at board independence, committee quality, and executive compensation detail. The 3% annual auto-increase in the equity plan needs scrutiny.

Competitive pricing dynamics. Watch SRS/HD organic growth vs. QXO organic growth. If HD continues gaining share at QXO's expense, the margin expansion thesis weakens -- you can't cut costs fast enough to offset share loss.

Monthly ARMA data. Shingle shipment volumes are the pulse check on residential roofing demand. Q1 2026 expected down low-20s% YoY due to storm comp; meaningful recovery needed in Q2-Q3.

Sources

All findings sourced from primary documents:

• QXO 10-K (filed Feb 27, 2026)
• QXO 8-Ks: Nov 5, 2025 (credit amendment); Nov 6 (Q3 earnings); Jan 5, 12 (Apollo Series C); Jan 15, 20 (equity offering); Feb 11 (Kodiak); Feb 25 (Q4 earnings)
• Beacon Predecessor Financials (FY2021-2024, Exhibits 99.1-99.3 in QXO 10-K)
• Beacon Q4 2024 Earnings Transcript (Feb 27, 2025 -- last pre-acquisition call)
• Counterparty Transcripts: OC Q2-Q4 2025, HD Q4 2025, BLDR Q4 2025, CSL Q4 2025, AMRZ Q4 2025, APO Q4 2025
• yfinance market data (Mar 3, 2026)
• Factor regression via iev regress (251 trading days)